Harmony Biosciences Holdings (HRMY)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 999,200 | 811,448 | 673,870 | 433,443 | 427,074 |
| Total stockholders’ equity | US$ in thousands | 659,155 | 466,992 | 402,838 | 186,507 | 97,180 |
| Financial leverage ratio | 1.52 | 1.74 | 1.67 | 2.32 | 4.39 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $999,200K ÷ $659,155K
= 1.52
The financial leverage ratio of Harmony Biosciences Holdings has shown a consistent downward trend over the past few years, indicating a decreasing reliance on debt to finance its operations. The ratio was 4.39 as of December 31, 2020, and has since decreased to 1.52 as of December 31, 2024. This reduction in the financial leverage ratio suggests that the company has been progressively reducing its debt levels in relation to its equity, which can indicate improved financial stability and lower risk of default. It is important to note that a lower financial leverage ratio generally indicates a stronger financial position for the company.
Peer comparison
Dec 31, 2024